Adents’ Premier Serialization Solutions Transcend Short-term Compliance to Address Long-term Manufacturing Needs
As the U.S. pharmaceutical industry breathes a collective sigh of relief, Adents is urging pharma manufacturers to take full advantage of the Drug Supply Chain Security Act’s one-year enforcement postponement.
ALREADY A REGISTERED USER? SIGN IN now
Subscribe (for free) to read this article
Become a subscriber to read this story, as well as other exclusive articles and interviews. The process is entirely free and takes no time at all.